Calton & Associates’s Arotech Corporation ARTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-31,436
Closed -$92K 304
2019
Q1
$92K Hold
31,436
0.03% 255
2018
Q4
$82K Sell
31,436
-5,006
-14% -$14K 0.03% 216
2018
Q3
$124K Sell
36,442
-970
-3% -$3.48K 0.04% 272
2018
Q2
$133K Hold
37,412
0.04% 274
2018
Q1
$114K Sell
37,412
-13,658
-27% -$46.6K 0.03% 331
2017
Q4
$181K Buy
+51,070
New +$197K 0.05% 364

Other funds holding ARTX

Calton & Associates's ARTX Position: Q2 2019 in Review

Calton & Associates sold out of Arotech Corporation (ARTX) in Q2 2019, closing a stake of 31,436 shares — an estimated $92K sold.

Calton & Associates first reported a position in ARTX in Q4 2017 and held it in 6 quarters. The position peaked at $181K in Q4 2017. 51 funds tracked by Wall St. Rank hold ARTX as of Q2 2019.

  • Calton & Associates reported no remaining Arotech Corporation position as of Q2 2019 after selling out during the quarter.
  • Calton & Associates sold 31,436 Arotech Corporation shares in Q2 2019, an estimated $92K.
  • Calton & Associates first reported a position in Arotech Corporation in Q4 2017 and held it in 6 quarters.
  • Calton & Associates's Arotech Corporation position peaked at $181K in Q4 2017.
  • 51 funds tracked by Wall St. Rank held Arotech Corporation as of Q2 2019.

Based on Calton & Associates's 13F filing for Q2 2019, filed 9 Jul 2019.